DDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress

被引:44
作者
Simonson, Bridget [1 ]
Subramanya, Vinita [2 ]
Chan, Mun Chun [1 ]
Zhang, Aifeng [1 ]
Franchino, Hannabeth [2 ]
Ottaviano, Filomena [2 ]
Mishra, Manoj K. [3 ]
Knight, Ashley C. [2 ]
Hunt, Danielle [2 ]
Ghiran, Ionita [2 ]
Khurana, Tejvir S. [3 ]
Kontaridis, Maria I. [2 ]
Rosenzweig, Anthony [1 ]
Das, Saumya [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Cardiovasc Res Ctr, Boston, MA 02115 USA
[3] Univ Penn, Penn Muscle Inst, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA
关键词
INDUCED HEART-FAILURE; MAMMALIAN TARGET; SIGNALING PATHWAY; MTORC1; ACTIVATION; SKELETAL-MUSCLE; AMINO-ACIDS; EXPRESSION; COMPLEX; GROWTH; OVEREXPRESSION;
D O I
10.1126/scisignal.aaf5967
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Physiological cardiac hypertrophy, in response to stimuli such as exercise, is considered adaptive and beneficial. In contrast, pathological cardiac hypertrophy that arises in response to pathological stimuli such as unrestrained high blood pressure and oxidative or metabolic stress is maladaptive and may precede heart failure. We found that the transcript encoding DNA damage-inducible transcript 4-like (DDiT4L) was expressed in murine models of pathological cardiac hypertrophy but not in those of physiological cardiac hypertrophy. In cardiomyocytes, DDiT4L localized to early endosomes and promoted stress-induced autophagy through a process involving mechanistic target of rapamycin complex 1 (mTORC1). Exposing cardiomyocytes to various types of pathological stress increased the abundance of DDiT4L, which inhibited mTORC1 but activated mTORC2 signaling. Mice with conditional cardiac-specific overexpression of DDiT4L had mild systolic dysfunction, increased baseline autophagy, reduced mTORC1 activity, and increased mTORC2 activity, all of which were reversed by suppression of transgene expression. Genetic suppression of autophagy also reversed cardiac dysfunction in these mice. Our data showed that DDiT4L may be an important transducer of pathological stress to autophagy through mTOR signaling in the heart and that DDiT4L could be therapeutically targeted in cardiovascular diseases in which autophagy and mTOR signaling play a major role.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] FNDC5/Irisin inhibits pathological cardiac hypertrophy
    Yu, Qing
    Kou, Wenxin
    Xu, Xu
    Zhou, Shunping
    Luan, Peipei
    Xu, Xiaopeng
    Li, Hailing
    Zhuang, Jianhui
    Wang, Jun
    Zhao, Yifan
    Xu, Yawei
    Peng, Wenhui
    CLINICAL SCIENCE, 2019, 133 (05) : 611 - 627
  • [2] Therapeutic potentials of modulating autophagy in pathological cardiac hypertrophy
    Shi, Shenggan
    Jiang, Peidu
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
  • [3] miR-222 inhibits pathological cardiac hypertrophy and heart failure
    Liu, Xiaojun
    Li, Haobo
    Hastings, Margaret H.
    Xiao, Chunyang
    Damilano, Federico
    Platt, Colin
    Lerchenmueller, Carolin
    Zhu, Han
    Wei, Xin Paul
    Yeri, Ashish
    Most, Patrick
    Rosenzweig, Anthony
    CARDIOVASCULAR RESEARCH, 2024, 120 (03) : 262 - 272
  • [4] Fisetin inhibits cardiac hypertrophy by suppressing oxidative stress
    Dong, Bin
    Liu, Chen
    Xue, Ruicong
    Wang, Yan
    Sun, Yu
    Liang, Zhuomin
    Fan, Wendong
    Jiang, Jingzhou
    Zhao, Jingjing
    Su, Qiao
    Dai, Gang
    Dong, Yugang
    Huang, Huiling
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2018, 62 : 221 - 229
  • [5] The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy
    Zhou, Lichun
    Ma, Baohua
    Han, Xiuzhen
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2016, 57 (04) : R143 - R152
  • [6] miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy
    Shi, Jia-yu
    Chen, Chu
    Xu, Xuan
    Lu, Qi
    ACTA PHYSIOLOGICA, 2019, 227 (02)
  • [7] mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy
    Song, Xiaoxiao
    Kusakari, Yoichiro
    Xiao, Chun-Yang
    Kinsella, Stuart D.
    Rosenberg, Michael A.
    Scherrer-Crosbie, Marielle
    Hara, Kenta
    Rosenzweig, Anthony
    Matsui, Takashi
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2010, 299 (06): : C1256 - C1266
  • [8] NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload
    Schnelle, Moritz
    Sawyer, Iain
    Anilkumar, Narayana
    Mohamed, Belal A.
    Richards, Daniel A.
    Toischer, Karl
    Zhang, Min
    Catibog, Norman
    Sawyer, Greta
    Mongue-Din, Heloise
    Schroeder, Katrin
    Hasenfuss, Gerd
    Shah, Ajay M.
    CARDIOVASCULAR RESEARCH, 2021, 117 (01) : 178 - 187
  • [9] AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1
    Li, Yanh
    Chen, Cong
    Yao, Fengj
    Su, Qiao
    Liu, Dan
    Xue, Ruic
    Dai, Gang
    Fang, Rong
    Zeng, Juny
    Chen, Yil
    Huang, Huil
    Ma, Yued
    Li, Wenw
    Zhang, Lil
    Liu, Chen
    Dong, Yug
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2014, 558 : 79 - 86
  • [10] Lipoxin A4 promotes autophagy and inhibits overactivation of macrophage inflammasome activity induced by Pg LPS
    Zhao, Jie
    Geng, Wenjing
    Wan, Kefei
    Guo, Kailei
    Xi, Fengjun
    Xu, Xiangqun
    Xiong, Xiujuan
    Huang, Xu
    Liu, Jiayi
    Kuang, Xiaodong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (02)